Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Effective and safe tumor inhibition using vinblastine in medulloblastoma.

Nobre L, Pauck D, Golbourn B, Maue M, Bouffet E, Remke M, Ramaswamy V.

Pediatr Blood Cancer. 2019 Jun;66(6):e27694. doi: 10.1002/pbc.27694. Epub 2019 Mar 8.

PMID:
30848061
2.

Adult medulloblastoma: multiagent chemotherapy.

Greenberg HS, Chamberlain MC, Glantz MJ, Wang S.

Neuro Oncol. 2001 Jan;3(1):29-34. doi: 10.1093/neuonc/3.1.29. Review.

3.

High dose chemotherapy with stem-cell transplantation in a metastatic medulloblastoma in an adult: a case report and review of the literature.

Cottu PH, Giacchetti S, Mignot L, Epardeau B, Visot B, Extra JM, Espie M, Marty M.

J Neurooncol. 1994;18(1):19-23. Review.

PMID:
7520058
5.

Can MOPP be replaced in the treatment of advanced Hodgkin's disease?

Canellos GP.

Semin Oncol. 1990 Feb;17(1 Suppl 2):2-6. Review.

PMID:
1689509
6.

SENSITIVITY OF INTRACRANIAL GLIOMAS TO VINCRISTINE SULPHATE.

LASSMAN LP, PEARCE GW, GANG J.

Lancet. 1965 Feb 6;1(7380):296-8. No abstract available.

PMID:
14247875
7.

Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.

Packer RJ, Sutton LN, Elterman R, Lange B, Goldwein J, Nicholson HS, Mulne L, Boyett J, D'Angio G, Wechsler-Jentzsch K, et al.

J Neurosurg. 1994 Nov;81(5):690-8.

PMID:
7931615
8.

Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.

Kortmann RD, Kühl J, Timmermann B, Mittler U, Urban C, Budach V, Richter E, Willich N, Flentje M, Berthold F, Slavc I, Wolff J, Meisner C, Wiestler O, Sörensen N, Warmuth-Metz M, Bamberg M.

Int J Radiat Oncol Biol Phys. 2000 Jan 15;46(2):269-79.

PMID:
10661332
9.

Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy.

Prados MD, Wara W, Edwards MS, Ater J, Rabbit J, Lamborn K, Davis R, Levin VA.

Pediatr Neurosurg. 1996 Oct;25(4):174-81.

PMID:
9293544
10.

Irinotecan, vincristine, cisplatin, cyclophosphamide, and etoposide for refractory or relapsed medulloblastoma/PNET in pediatric patients.

Kim H, Kang HJ, Lee JW, Park JD, Park KD, Shin HY, Ahn HS.

Childs Nerv Syst. 2013 Oct;29(10):1851-8. doi: 10.1007/s00381-013-2163-z. Epub 2013 Jun 9.

PMID:
23748464
12.

Prospective clinical trial to compare vincristine and vinblastine in a COP-based protocol for lymphoma in cats.

Krick EL, Cohen RB, Gregor TP, Salah PC, Sorenmo KU.

J Vet Intern Med. 2013 Jan-Feb;27(1):134-40. doi: 10.1111/jvim.12006. Epub 2012 Nov 17.

13.

Medulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy.

Zhang ZY, Xu J, Ren Y, Li KK, Ng HK, Mao Y, Zhong P, Yao Y, Zhou LF.

PLoS One. 2014 Jun 16;9(6):e99490. doi: 10.1371/journal.pone.0099490. eCollection 2014. Erratum in: PLoS One. 2014;9(9):e107855. PLoS One. 2014;9(8):e105742.

14.

Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.

Packer RJ, Goldwein J, Nicholson HS, Vezina LG, Allen JC, Ris MD, Muraszko K, Rorke LB, Wara WM, Cohen BH, Boyett JM.

J Clin Oncol. 1999 Jul;17(7):2127-36.

PMID:
10561268
15.
16.

Treatment of standard risk medulloblastoma with craniospinal irradiation, carboplatin, and vincristine.

Bergman I, Jakacki RI, Heller G, Finlay J.

Med Pediatr Oncol. 1997 Dec;29(6):563-7.

PMID:
9324345
17.

Medulloblastoma: conventional radiation therapy in comparison to chemo radiation therapy in the post-operative treatment of high-risk patients.

Abd El-Aal HH, Mokhtar MM, Habib E, El-Kashef AT, Fahmy ES.

J Egypt Natl Canc Inst. 2005 Dec;17(4):301-7.

18.

Raynaud's phenomenon in a child with medulloblastoma as a late effect of chemotherapy.

Atas E, Korkmazer N, Artik HA, Babacan O, Kesik V.

J Cancer Res Ther. 2015 Jul-Sep;11(3):666. doi: 10.4103/0973-1482.144649.

19.

Synergistic action of genistein and cisplatin on growth inhibition and cytotoxicity of human medulloblastoma cells.

Khoshyomn S, Manske GC, Lew SM, Wald SL, Penar PL.

Pediatr Neurosurg. 2000 Sep;33(3):123-31.

PMID:
11096359
20.

Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study.

Strother D, Ashley D, Kellie SJ, Patel A, Jones-Wallace D, Thompson S, Heideman R, Benaim E, Krance R, Bowman L, Gajjar A.

J Clin Oncol. 2001 May 15;19(10):2696-704.

PMID:
11352962

Supplemental Content

Support Center